Skip to content
★ Sign in to follow
MC

Michael Craig Pine

Directeur du Développement Corporatif et Stratégique
EyePoint Pharmaceuticals, Inc.
Total declarations
8
Company
1
▲ Purchases (1 ops.)
€11k
▼ Sales (3 ops.)
€1.8M

Latest filing published 09 Jan 2024 for EyePoint Pharmaceuticals, Inc..

Filing timeline

BuySale
Michael Craig Pine

Insider track record

Disclosed buys
1
Disclosed sells
3

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Michael Craig Pine: trading record in brief

Michael Craig Pine, listed as senior executive, appears in our data through filings on EyePoint, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 14 March 2022 to 6 January 2024, the count stands at 8 filings.

Both buying and selling appear: 1 purchase worth €11k, against 3 sales worth €1.8M. Netting one side against the other leaves €1.8M of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 share grant and 3 option exercises.

Most recently, on 9 January 2024, the filings show a share grant worth €111k in EyePoint, Inc. The clock since the last published purchase (15 March 2022) now reads 1,701 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Michael Craig Pine

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total

4 of 4 declarations